Ultragenyx Pharmaceutical | RARE - Ebit

Prezzo Delle Azioni
24.10
Cambio Giornaliero
-0.18 -0.74%
Mensile
21.41%
Annuale
-36.73%
Q2 Previsione
23.58




Ebit Cambiamento Data
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Immunic USD -22.81M 756K 2024-06
Insmed USD -249.71M 11.64M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Karyopharm Therapeutics USD -17.84M 8.44M 2025-12
Kyowa Hakko Kirin JPY 38.35B 12.49B 2025-12
MacroGenics USD -12.1M 32.26M 2025-12
Moderna USD -857M 597M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Xoma USD -10.08M 4.4M 2024-06